Supply Chain/Logistics

A new technical report guides bio/pharma companies in establishing a risk-based approach for prevention and management of drug shortages.

Manufacturers face new rules for tracing drugs through the supply chain and compounders face stricter standards.

A guidance document published just before the Jan. 1, 2015 deadline adds a four-month grace period.

Dual sourcing is one of many possible solutions to securing the supply chain.

For cellular therapies to become a viable treatment for large-sized patient groups, steps need to be taken to develop an efficient manufacturing and supply system to minimise the cost of goods.

Regulations, product protection, and cost management are top concerns of supply chain decision makers.

Defining best biopharmaceutical practices is necessary to ensure the safety of the supply chain.

Supplier Audit Program Marks Progress

With globalization, biopharmaceutical companies must establish strategies to minimize vulnerabilities in the raw-materials supply chain.

Challenges in Securing the Biopharma Supply Chain

Aesica Pharmaceuticals S.r.I. collaborates with QAD to meet China's Food and Drug Administration's shortened serialization deadline.

New identifiers and tracking requirements aim to block illegitimate products.

Vetter launches new serialization process to support track-and-trace efforts.

For single-use systems, supply chain excellence requires a commitment to problem solving across organization boundaries.

For single-use systems, supply chain excellence requires a commitment to problem solving across organization boundaries.

Thirteen companies are accepted for participation in the supply chain program.

The international “Fight the Fakes” campaign will raise awareness about the dangers of counterfeit medicines.

Almac releases an enhanced third-party logistics customer billing application.

BioPharm International speaks with industry experts about challenges faced in managing the cold chain.

New FDA supply chain policies aim to strengthen inspection and oversight processes.

Bills to regulate drug compounding and establish a national track and trace system face political and policy differences.

New Center for Pharmaceutical Advancement and Training increases number of experts and available tools in Sub-Saharan countries.

INTERPOL and 29 of the world's largest pharmaceutical companies have joined forces in an initiative to battle counterfeit drugs.

A Q&A with SAFC and BioReliance about sourcing and risk mitigation for raw materials.

An operation spanning 16 African countries and conducted by the World Customs Organization (WCO) in partnership with the Institute of Research against Counterfeit Medicines (IRACM) led to the seizure of more than 82 million doses of counterfeit medicines.